EHR-integrated rUTI Texting Platform (Urotrust)

University of Pennsylvania

Status: Active, not recruiting

Conditions: Recurrent Urinary Tract Infection

Treatments: Device: EHR-integrated texting platform (Urotrust); Other: Usual care

Study type: Interventional

Funder types: Other

Identifiers

NCT06035601

853917

Details and patient eligibility

About

The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI).

The main question it aims to answer is:

• can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care?

Participants enrolled onto the texting platform will:

• receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.

Enrollment: 104 patients

Sex: Female

Ages: 18 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Provision of signed and dated informed consent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Females who currently meet the criteria for recurrent UTIs
4. Age 18 years or older
5. Owns a mobile device with text messaging capability
6. Ability to read and write English
7. Currently receiving care from a provider in Penn Urogynecology or Penn Urology

Exclusion criteria

1. History of known multidrug resistant UTIs
2. History of interstitial cystitis/bladder pain syndrome or current diagnosis of chronic pelvic pain
3. On continuous suppressive antibiotics currently
4. Currently pregnant or within 6 weeks of pregnancy
5. Transplant patient on immunosuppressive medication currently
6. Practice of chronic self-catheterization

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

104 participants in 2 patient groups

Electronic health record (EHR)-integrated texting platform

Experimental group

Description:

Patients will be enrolled into a texting platform for the management of recurrent UTI.

Treatment:

Device: EHR-integrated texting platform (Urotrust)

Usual care

Active Comparator group

Description:

Patients will receive usual care through their providers.

Treatment:

Other: Usual care